Arbutus Biopharma Corp (NASDAQ:ABUS)

4.38
Delayed Data
As of Dec 14
 -0.01 / -0.23%
Today’s Change
4.01
Today|||52-Week Range
12.60
-13.27%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close4.39
Today’s open4.35
Day’s range4.33 - 4.59
Volume215,066
Average volume (3 months)374,332
Market cap$259.6M
Data as of 4:00pm ET, 12/14/2018

Growth & Valuation

Earnings growth (last year)+78.45%
Earnings growth (this year)+29.17%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+617.64%
P/E ratioNM
Price/Sales25.83
Price/Book1.94

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc-0.07-3.52%
BDSIBioDelivery Sciences...-0.14-3.79%
ADROAduro Biotech Inc+0.01+0.37%
CNCEConcert Pharmaceutic...+0.08+0.60%
Data as of 4:00pm ET, 12/14/2018

Financials

Next reporting dateMarch 7, 2019
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$10.7M
Annual profit (last year)-$84.4M
Net profit margin-788.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer
David C. Hastings
Corporate headquarters
Burnaby, British Columbia

Forecasts